Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH)

Historical Holders from Q3 2023 to Q3 2025

Symbol
DNTH on Nasdaq
CUSIP
252828108
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
42.9M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
46.8M
Holdings value
$1.84B
% of all portfolios
0.014%
Grand Portfolio weight change
+0.001%
Number of holders
139
Number of buys
93
Number of sells
-46
Average Value change %
+0%
Average buys %
+0.005%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +7.14% $235M $58.6M 5.97M +33.2% FMR LLC Sep 30, 2025
Fairmount Funds Management LLC 9.9% $76.3M 4.05M Fairmount Funds Management LLC Sep 11, 2025
RA CAPITAL MANAGEMENT, L.P. 9.5% +6.67% $152M $39.4M 3.87M +34.9% RA Capital Management, L.P. Sep 30, 2025
WELLINGTON MANAGEMENT GROUP LLP 6.5% $101M 2.58M Wellington Management Group LLP Sep 30, 2025
Octagon Capital Advisors LP 6.1% -14.3% $95.1M $12.1M 2.42M +14.5% Octagon Capital Advisors LP Sep 30, 2025
Point72 Asset Management, L.P. 5.3% -10% $40M $4.27M 2.12M +12% Point72 Asset Management, L.P. Sep 11, 2025
Avidity Partners Management LP 4.9% -50% $71M -$43M 2.1M -37.7% Avidity Partners Management LP Nov 17, 2025
BlackRock, Inc. 5% $25M 1.6M BlackRock, Inc. Mar 31, 2025
TCG Crossover GP II, LLC 4.7% $23.4M 1.5M TCG Crossover GP II, LLC Mar 31, 2025
BCLS Fund III Investments, LP 3.1% -55% $51.8M -$45.9M 1.32M -47% BCLS Fund III Investments, LP Sep 30, 2025
Vestal Point Capital, LP 3% -69.5% $46.4M -$79.5M 1.18M -63.1% Vestal Point Capital, LP Sep 30, 2025
Venrock Healthcare Capital Partners III, L.P. 3.1% $24.8M 1M Venrock Healthcare Capital Partners III, L.P. Jun 30, 2025

Institutional Holders of Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 46.8M $1.84B +$358M $39.35 139
2025 Q2 39.1M $729M +$24.4M $18.63 101
2025 Q1 37.7M $685M +$43.2M $18.14 97
2024 Q4 35.1M $766M +$63.2M $21.80 94
2024 Q3 31.4M $859M +$44.8M $27.38 90
2024 Q2 29.7M $769M +$87.6M $25.88 74
2024 Q1 26.1M $782M +$479M $30.00 75
2023 Q4 10.3M $107M +$520K $10.40 38
2023 Q3 10.1M $136M +$136M $13.67 30